0001127602-15-004139.txt : 20150203 0001127602-15-004139.hdr.sgml : 20150203 20150203190727 ACCESSION NUMBER: 0001127602-15-004139 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150130 FILED AS OF DATE: 20150203 DATE AS OF CHANGE: 20150203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: (805)447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Meline David W CENTRAL INDEX KEY: 0001444612 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12477 FILM NUMBER: 15572936 MAIL ADDRESS: STREET 1: 3M COMPANY STREET 2: 3M OFFICE OF GENERAL COUNSEL CITY: ST PAUL STATE: MN ZIP: 55144-1000 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2015-01-30 0000318154 AMGEN INC AMGN 0001444612 Meline David W ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 1 EVP & CFO Common Stock 2015-01-30 4 A 0 3940 0 A 58537 D These Restricted Stock Units (RSUs) were granted under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 1/30/2017, 1/30/2018 and 1/30/2019, respectively. These shares include the following RSUs granted under the Company's equity plans: 54,161 RSUs which vest in three equal installments of 13,540 on 8/1/2015, 8/1/2016 and 8/1/2017 and one installment of 13,541 on 8/1/2018; and 3,940 RSUs whicdh vest in two equal installments of 1,300 on 1/30/2017 and 1/30/2018 and one installment of 1/340 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. These shares include 436 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting persons' unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Andrea A. Robinson, Attorney-in-Fact for Mr. Meline 2015-02-03